Introduction
Asbestos is a well-established human carcinogen and induces both bronchogenic carcinoma and mesothelioma. The genotoxic/carcinogenic mechanism of asbestos and other carcinogenic ®bers, however, are not clear. Various in vitro genotoxic studies have been employed to assess the in vivo carcinogenic potential of mineral ®bers. Studies using mammalian cell models have suggested that ®ber dimension, surface properties, physical durability, and cell and tissue responses are important criteria for the carcinogenicity of asbestos ®bers (Stanton et al., 1977; Mossman et al., 1990) . The mutagenic eects of asbestos in mammalian cells have been demonstrated using several model systems that can detect large multilocus deletions (Hei et al., 1992; Park and Aust, 1998; Lezon-Geyda et al., 1996) . These ®ndings provide a direct link between chromosomal abnormalities that have frequently been demonstrated in ®ber exposed human and rodent cell lines and carcinogenicity in vivo.
Using immortalized human bronchial epithelial (BEP2D) cells, we showed previously that a single, 7 day treatment with a 4 mg cm 2 dose of chrysotile ®bers induced malignant transformation of these cells in a stepwise fashion at a frequency of *10 -7 (Hei et al., 1997) . Although BEP2D cells are immortalized by HPV-18 that disturbs both normal p53 and RB functions, they are non-tumorigenic even in late passage (Hei et al., 1994 (Hei et al., , 1997 (Hei et al., , 1998 . This suggests that additional genetic alterations are needed in the tumorigenic conversion of these cells by asbestos. Using cDNA expression arrays, we identi®ed a series of 11 dierentially expressed genes between tumorigenic and control BEP2D cells (Zhao et al., 2000) . Among these genes, several have been shown to be associated with stress response and cell cycle regulation such as c-fos, DNA-PK, NFkB and p21
Cip1 . Deregulations in cell cycle progression and cellular proliferation are hallmarks of neoplastic transformation (Kamb et al., 1994; Nobori et al., 1994) . The tumor suppressor protein p16, a speci®c inhibitor of the cdk4/cyclin D kinase, plays an important suppressive role in the neoplastic process. Alteration in p16 protein expression level, mutation and homozygous deletion of the p16 gene are frequently detected in human cancers including mesothelioma and lung cancer (Okamoto et al., 1994; Cheng et al., 1994; Washimi et al., 1995) . Under normal conditions, cyclindependent kinases (cdks) exist predominantly in multiple quaternary complexes, each containing a cdk, cyclin, proliferating cell nuclear antigen and the p21
Cip1
. p21
Cip1 is one of several kinase inhibitors that are known to control cell proliferation. There are striking changes in the subunit composition of the cdk in many transformed cells. reported that p21
Cip1 inhibits the activity of each member of the cyclin/CDK family and indicated that p21
Cip1 may be a universal inhibitor of cdks. Recent evidence indicates that a disruption in the p21 Cip1 gene may result in an increased susceptibility of mice to chemically induced Oncogene (2001) 20, 7301 ± 7306 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc skin carcinomas (Gabrielle et al., 1999) . Both p16 and p21
Cip1 are important regulators of cell growth whose aberrant expressions may lead to carcinogenesis including lung cancer. However, there are few data available about the relationship between alterations of p16 and p21
Cip1 gene expression and tumorigenesis induced by asbestos. In this study, alterations in the p16 gene, as well as expression of p21
Cip1 mRNA, together with their protein levels were analysed in tumor cell lines derived from asbestos treated BEP2D cells. The results were compared with control BEP2D cells, normal human bronchial epithelial cells (NHBE) and a fusion cell line generated by the fusion of tumor and control BEP2D cells and were no longer tumorigenic. Our data suggest that down-regulation of p21
Cip1 expression is crucial to the tumorigenic phenotype of BEP2D cells induced by asbestos treatment.
Results

Origin of tumor cell lines
The various tumorigenic and control cell lines used in the study are shown in Figure 1 . Primary tumor cell lines were generated previously, and secondary tumors were established by injecting primary tumor cell lines into nude mice as described (Hei et al., 1997) . These tumors had a shorter latency period compared with the primary tumors (*2 ± 3 weeks versus 3 ± 4 months). Fusion cell lines were generated by fusing secondary tumor lines with control BEP2D cells as previously described (Zhao et al., 2000) . These fusion cells were no longer tumorigenic when inoculated into nude mice.
Alterations in p16 gene and protein levels
Analysis of p16 protein by Western blot among ®ve tumorigenic cell lines showed a fairly uniform expression level that was similar to that of control BEP2D cells (Figure 2) . However, this level was *3-fold higher than that of NHBE cells (Figure 2a,b) . Immunohistochemical staining using p16 speci®c polyclonal antibody indicated that most of the protein was located in the nuclear compartment and in quantities consistent with the results obtained with Western blot (Figure 3) . Analysis of the p16 gene by PCR ampli®cation showed no deletion in any of the three exons of the gene among all the tumor cell lines as well as in control BEP2D cells examined (data not shown).
Expression of p21
Cip1 in tumorigenic cells
In contrast to p16, the cyclin-CDK inhibitor p21 dierence in the p21 Cip1 expression level was detected between BEP2D and NHBE cells using Western blot. Furthermore, based on immunocytochemical staining, the p21 protein expression levels were similar to those detected by Western blot and the protein was localized exclusively in the nuclei ( Figure 5 ). Figure 6 shows the expression of p21
Cip1 mRNA by Northern blot in tumor cell lines relative to the controls and a representative fusion cell line. The p21
Cip1 mRNA was down regulated about 2.8-fold in all of the tumor cell lines examined ( Figure 6 , lanes 2 ± 6) compared with control BEP2D cells (lane 1). In addition, fusion of tumorigenic cells with control BEP2D cells not only abrogated the tumorigenic phenotype, but restored the expression of p21
Cip1 mRNA in all four fusion cell lines examined (Figure 6a,b) .
Discussion
The mechanisms of ®ber carcinogenesis are poorly understood. Asbestos induces chromosomal aberrations, sister chromatid exchanges, and multilocus deletions in mammalian cells (Lechner et al., 1985; Livington et al., 1980; Hei et al., 1992) . In addition, human chromosomal fragments that are frequently found to be deleted in asbestos-associated lung and mesothelial tumors, such as chromosomes 3p, 6q, 9p, 13q, and 22q (Xiao et al., 1995; Gerwin, 1994) , are often sites containing genes with known tumor suppressor functions.
p16 is an inhibitor of the cyclin dependent kinase cdk4, and the gene is regionally mapped to 9p21 (Kamb et al., 1994; Nobori et al., 1994) . Although mutations in the p16 gene including homozygous deletions are common in human lung cancers (Okamoto et al., 1994; Cheng et al., 1994; Washimi et al., 1995) , we did not ®nd any such changes in any of our tumorigenic cell lines examined based on PCR ampli®cation of the three exons of the gene. This approach, however, cannot rule out the presence of are reciprocally inactivated in primary lung cancer (Shapiro et al., 1995) . The levels of p16 protein are signi®cantly elevated in human cells carrying either inactivating mutations of Rb or expression of viral oncoproteins such as HPV-16 E7, SV40 T-antigen, or adenovirus E1a (Serrano, 1997) . BEP2D cell line is immortalized by HPV-18 and expresses both E6 and E7 oncoproteins. Our present ®nding that tumor cell lines and BEP2D cells have a higher expression level of p16 protein compared with normal human bronchial epithelial cells (NHBE) is consistent with the concept that p16 expression is regulated by Rb. These ®ndings are also consistent with the observation that induction of p16 occurs during the immortalization step by HPV 16 and 18 and not during malignant transformation of the immortalized cells in response to carcinogen treatment (Nakao et al., 1997) . p21 Cip1 is the ®rst cyclin-dependent kinase (CDK) inhibitor identi®ed as a mediator of p53 in DNA damaged-induced growth arrest. p21
Cip1 protein inhibits the activity of cyclin-Cdk complexes and suppresses cell cycle progression. There is recent evidence that p21
Cip1 level is associated with an aggressive tumorigenic behavior in ras-oncogene transformed primary keratinocytes derived from p21 Cip1 knockout mice (Missero et al., 1996) . Furthermore, over-expression of p21
Cip1 in human glioma cells induces cell dierentiation and growth inhibition (Kokunai et al., 1998) . Our present ®ndings that The results were further supported by the ®ndings with the non-tumorigenic fusion cell lines in which the expression of p21
Cip1 mRNA was restored to the control levels. These data provide strong evidence that down-regulation of p21
Cip1 mRNA expression correlated with tumorigenesis in BEP2D cells treated by asbestos. Our results are also consistent with the report that expression of p21 mRNA level is signi®cantly lower in malignant human bronchial epithelial cell lines than in normal bronchial epithelial cells (DeMuth et al., 1998) .
Although p21 Cip1 is a downstream eector of the p53 gene and can be transcriptionally induced by elevated level of wild-type p53 protein, there is evidence that its expression in some human tumors, including lung, is p53 independent and may be associated with cellular dierentiation (Nadal et al., 1997; Marchetti et al., 1996; Takeshima et al., 1998) . Several alternative pathways including TGF-b have been suggested to modulate p21
Cip1 expression Qiu et al., 1996) . These ®ndings are consistent with the observation that in HPV-immortalized cells, basal DNA damage inducible p53 functions are intact (Butz et al., 1995) . Therefore, the use of these cells and the study of p21
Cip1 mutations are not necessarily mutually exclusive. However, the downstream regulatory pathways of p21
Cip1 whose aberrant functions are associated with tumorigenic conversion of BEP2D cells by asbestos remain to be elucidated.
Materials and methods
Cell culture
The immortalized human bronchial epithelial (BEP2D) cells, tumor and fusion cells were all cultured in serum-free LHC-8 medium supplemented with growth factors as described (Hei et al., 1997) . Normal human bronchial epithelial (NHBE) cells and serum free BEBM medium were purchased from Clonetics (BioWhitter, San Diego, CA, USA). Cells from passages 4 ± 6 were used in this study.
Detection of p16 gene deletion by PCR
PCR analysis was performed for each of the three exons of p16 gene. The primers used were exon 1: 5-GGAGGAA-GAAAGAGGAGGG-3, 5-ACTTCGTCCTCCAGAGTCG-3; exon 2: 5-TCTGACCATTCTGTTCTCTC-3, 5-CTCAGCTTTGGAAGCTCTCA-3; exon 3: 5-GGATGTTC-CACACATCTTTG-3, 5-ATGAAAACTACGAAAGCGGG-3 (Cheng et al., 1994) . DNA was isolated from tumor cell lines, and ampli®ed using Ready To Go PCR Beads (Amersham Pharmacia Biotech, Piscataway, NJ, USA). Following the manufacturer's instruction, 100 ng of DNA and 0.5 mM of each primer sets were added to 25 ml reaction mixture with 35 cycles of ampli®cation consisted of 1 min at 948C, 1 min at 588C, and 1 min at 728C. The PCR products were analysed by electrophoresis in 2.0% agarose gel.
Detection of p16 and p21
Cip1 protein by immunocytochemical staining Cells were grown in glass chamber slides for 3 days and then ®xed with acetone for 20 min at 7208C. For detecting p16 and p21
Cip1 expression and their location in cells, p16 and p21
Cip1 polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) coupled with Vectastain ABC kit and DAB substrate kit (Vector Lab. Inc., Burlingame, CA, USA) were used according to the manufacturer's instruction.
Analysis of p16 and p21
Cip1 protein expression by Western blot
Protein was extracted from approximately 10 7 cells by lysis in extraction buer (50 mM Tris-HC1 (pH 8), 150 mM NaC1, 1% NP-40, 0.1% sodium dodecyl sulfate (SDS), 1 mM phenylmethylsulfonyl¯uoride). All experimental and control cultures were processed at *80% con¯uence to ensure that they were in similar growth conditions. Concentration of protein was determined by Bio-Rad Protein Assay. Equivalent amounts of protein (100 mg) were fractionated by electrophoresis in SDS-polyacrylamide gel. The proteins were subsequently transferred to Immobilon-P nitrocellulose membrane (Bio-Rad) under semi-dry conditions. The same p16 and p21
Cip1 polyclonal primary antibodies used in immunocytochemical staining and b-actin antibody (Sigma) were used. Immuno-reactive p16, p21
Cip1 and b-actin proteins were detected by enhanced chemiluminescence system (Amersham) according to the manufacturer's instruction. The band of protein expression was quanti®ed by using NIH image software and normalized to the b-actin expression level.
Analysis of p21
Cip1 mRNA level of Northern blot poly(A) + RNA was isolated from total RNA extracted from tumor cell lines, fusion cell lines and control BEP2D cells using the Oligorex mRNA Mini kit (Qiagen). The parallel lanes of poly(A) + RNA were separated on a denaturing 1% agarose formaldehyde gel and then transferred to nylon membrane (Millipore Corp. Bedford) by downward capillary blotting in 206SSC (3 M NaC1, 0.3 M sodium citrate´2H 2 O, pH 7.0) and cross-linked by U.V. light. Speci®c probe was generated by labeling of re-ampli®ed cDNA fragment with a-32 P-dCTP using Random Primed DNA labeling kit (Boehringer, Mannheim). Blots were prehybridized for 30 min, and then hybridized with 32 P-labeled-cDNA probe using ExpressHyb TM Hybridization solution (Clonetech) for 6 ± 8 h at 688C. The membrane was washed twice in 26SSC, 0.1% SDS at room temperature for 15 min followed by washing twice in 0.26SSC, 0.15 SDS at 558C for 15 min. The membrane was exposed to Koday BioMAX ®lm at 7708C for 12 ± 72 h. Bands were quanti®ed by phosphorimaging and normalized to the b-actin expression level.
